Rivagelan® contains the active substance rivastigmine.

Rivastigmine belongs to a group of active substances called cholinesterase inhibitors. In patients with Alzheimer’s disease, certain nerve cells in the brain die, resulting in low levels of the neurotransmitter acetylcholine (a substance that enables nerve cells to communicate with each other).

Rivagelan® is used to treat adult patients with mild to moderate Alzheimer’s dementia, a progressive disease of the brain that gradually affects memory, intellectual ability and behaviour.

Product details

Active substance: Rivastigmine

Strength Pack size Dosage form Appearance
4,6 mg/24 h 7, 30 Transdermal patches
9,5 mg/24 h 7, 30 Transdermal patches

Physicians / Pharmacists Login

We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.